# reload+after+2024-01-21 09:46:12.168735
address1§9490 NeoGenomics Way
city§Fort Myers
state§FL
zip§33912
country§United States
phone§239 768 0600
fax§239 690 4237
website§https://www.neogenomics.com
industry§Diagnostics & Research
sector§Healthcare
longBusinessSummary§NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. The company also provides molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization, as well as acts as a reference laboratory supplying anatomic pathology testing services. It has a strategic alliance agreement and laboratory services agreement with Inivata Limited. The company was founded in 2001 and is headquartered in Fort Myers, Florida.
fullTimeEmployees§2100
companyOfficers§[{'maxAge': 1, 'name': 'Mr. Christopher Michael Smith BSc', 'age': 60, 'title': 'CEO & Director', 'yearBorn': 1963, 'fiscalYear': 2022, 'totalPay': 3517253, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Jeffrey S. Sherman M.B.A.', 'age': 57, 'title': 'Chief Financial Officer', 'yearBorn': 1966, 'fiscalYear': 2022, 'totalPay': 492310, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Vishal  Sikri', 'age': 47, 'title': 'President of Advanced Diagnostics Division', 'yearBorn': 1976, 'fiscalYear': 2022, 'totalPay': 1209097, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Warren  Stone', 'age': 50, 'title': 'President of Clinical Division', 'yearBorn': 1973, 'fiscalYear': 2022, 'totalPay': 722794, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Cynthia J. Dieter', 'age': 48, 'title': 'Chief Accounting Officer', 'yearBorn': 1975, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Greg  Sparks', 'title': 'Chief Technology Officer', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Kendra  Sweeney', 'title': 'Vice President of Investor Relations & Communications', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Alicia  Olivo', 'age': 39, 'title': 'General Counsel & Corporate Secretary', 'yearBorn': 1984, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Hutan  Hashemi J.D.', 'age': 44, 'title': 'Chief Compliance Officer', 'yearBorn': 1979, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Derek  Lyle M.D.', 'title': 'Chief Medical Officer', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}]
auditRisk§4
boardRisk§2
compensationRisk§10
shareHolderRightsRisk§3
overallRisk§7
governanceEpochDate§1704067200
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§2
payoutRatio§0.0
beta§1.209
priceToSalesTrailing12Months§3.4616528
currency§USD
dateShortInterest§1702598400
forwardEps§-0.07
pegRatio§0.95
exchange§NCM
quoteType§EQUITY
shortName§NeoGenomics, Inc.
longName§NeoGenomics, Inc.
firstTradeDateEpochUtc§1079447400
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§d9cfaccb-b46b-3e60-b471-fcbb35752f40
gmtOffSetMilliseconds§-18000000
targetHighPrice§26.0
targetLowPrice§17.0
targetMeanPrice§20.45
targetMedianPrice§19.0
recommendationMean§1.9
recommendationKey§buy
numberOfAnalystOpinions§11
quickRatio§5.778
grossMargins§0.40682
ebitdaMargins§-0.06621
trailingPegRatio§None
